FDA to approve more ‘boosters’ before human trials complete
The FDA is set to approve yet another ‘booster’ shot for COVID-19 despite human testing not being completed.
The FDA is set to approve yet another ‘booster’ shot for COVID-19 despite human testing not being completed.
New York City is one of the most expensive markets worldwide. Due to surging housing costs, high taxes and the negative effects of COVID-lockdowns, a rising number of New York residents are fleeing the Big Apple.